StockTipsArenaBeta

SELL Laurus Labs Ltd — Goldman Sachs

SELLLaurus Labs Ltd
Laurus Labs share price target & all analyst calls

byGoldman SachsHorizon: NA (inferred 1 year)28 Oct 2026via ET Now (Live)

Entry₹2,142Inferred
Target₹1,855
Total upside +13.40%
Stop lossNot given
CMP₹2,181.96h ago
Active-1.86%+14.98%upside left 12 mo left
Follow Goldman Sachs for new calls(100% target hit, 31 closed calls)Get alertsWatch LAURUSLABS for new buy/sell callsGet alertsSee 5 other Long-term calls on LAURUSLABSSee 200 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 28 Oct, 10:32 pm IST
1 supporting7 neutral14 opposing
Supports the SELL call (1)

1 other SEBI-registered advisor has an active long-term SELL call on this stock, issued in the last 14 days

Advisor consensus · same horizon·26 Oct · 2d ago

Neutral / worth noting (7)

Q2 FY27 results scheduled — board meets 29 Oct 2026

BSE · Board Meeting·29 Oct · today

(opens in new tab)

Laurus Labs invested INR 1.078 billion in its joint venture KRKA Pharma Private Limited via a rights issue, maintaining its 49% stake.

BSE · Company Update·14 Oct · 2w ago

(opens in new tab)
Weighs against the SELL call (14)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·28 Oct · today

3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days

Advisor consensus · same horizon·28 Oct · today

Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upside

NewsEt-Markets·16 Oct · 2w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·16 Oct · 2w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Laurus Labs

All analyst calls on Laurus Labs

More from Goldman Sachs

Every call and its outcome